| Year |
Citation |
Score |
| 2014 |
Dankoski EC, Agster KL, Fox ME, Moy SS, Wightman RM. Facilitation of serotonin signaling by SSRIs is attenuated by social isolation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2928-37. PMID 24981046 DOI: 10.1038/Npp.2014.162 |
0.305 |
|
| 2011 |
Floyd WC, Datta GK, Imamura S, Kieler-Ferguson HM, Jerger K, Patterson AW, Fox ME, Szoka FC, Fréchet JM, Ellman JA. Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing mice. Chemmedchem. 6: 49-53. PMID 20973119 DOI: 10.1002/Cmdc.201000377 |
0.611 |
|
| 2009 |
Fox ME, Guillaudeu S, Fréchet JM, Jerger K, Macaraeg N, Szoka FC. Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates. Molecular Pharmaceutics. 6: 1562-72. PMID 19588994 DOI: 10.1021/Mp9001206 |
0.736 |
|
| 2009 |
Fox ME, Szoka FC, Fréchet JM. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Accounts of Chemical Research. 42: 1141-51. PMID 19555070 DOI: 10.1021/Ar900035F |
0.626 |
|
| 2009 |
Nasongkla N, Chen B, Macaraeg N, Fox ME, Fréchet JM, Szoka FC. Dependence of pharmacokinetics and biodistribution on polymer architecture: effect of cyclic versus linear polymers. Journal of the American Chemical Society. 131: 3842-3. PMID 19256497 DOI: 10.1021/Ja900062U |
0.522 |
|
| 2008 |
Guillaudeu SJ, Fox ME, Haidar YM, Dy EE, Szoka FC, Fréchet JM. PEGylated dendrimers with core functionality for biological applications. Bioconjugate Chemistry. 19: 461-9. PMID 18173227 DOI: 10.1021/Bc700264G |
0.71 |
|
| 2006 |
Lee CC, Gillies ER, Fox ME, Guillaudeu SJ, Fréchet JM, Dy EE, Szoka FC. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proceedings of the National Academy of Sciences of the United States of America. 103: 16649-54. PMID 17075050 DOI: 10.1073/Pnas.0607705103 |
0.677 |
|
| Show low-probability matches. |